@moominmomma1234
Look at the declarations of interest. Companies including Pfizer have paid the researchers to publish this
Ethics
The study has been approved by the ethics board of the Universitätsmedizin Greifswald. Consent has been obtained to publish the case report.
Conflicts of interest:
Dr. Greinacher reports grants and non-financial support from Aspen, Boehringer Ingelheim, MSD, Bristol Myers Squibb (BMS), Paringenix, Bayer Healthcare, Gore Inc., Rovi, Sagent, Biomarin/Prosensa, personal fees from Aspen, Boehringer Ingelheim, MSD, Macopharma, BMS, Chromatec, Instrumentation Laboratory, non-financial support from Boehringer Ingelheim, Portola, Ergomed, GTH e.V. outside the submitted work.
Dr. Thiele reports grants from Deutsche Forschungsgemeinschaft, during the conduct of the study; personal fees and other from Bristol Myers Squibb, personal fees and other from Pfizer, personal fees from Bayer, personal fees and other from Chugai Pharma, other from Novo Nordisk, personal fees from Novartis, other from Daichii Sankyo, outside the submitted work.
Dr. Warkentin reports personal fees from Aspen Global, Ergomed, Instrumentation Laboratory, and Octapharma, all of which are outside of the submitted work.
Dr. Weisser has nothing to disclose.
Dr. Kyrle reports personal fees from Takeda and Novo Nordisk, all of which are outside of the submitted work
Dr. Eichinger reports personal fees from Bayer, Bristol Myers Squibb, Daichii Sankyo, and Pfizer, all of which are outside of the submitted work.
Author contributions:
AG, TT and TEW developed the concept of the mechanism; KW collected all reported cases and organized sample transfer; PK and SE identified and treated the index patient and suspected a HIT like syndrome